Real-World Evidence of Atezolizumab Efficacy as Part of First-Line Treatment for Extensive-Stage SCLC in Bulgaria.
Simple Summary: Small cell lung cancer accounts for a relatively small share of lung cancer cases, yet is highly lethal, without notable advances in treatment approaches over the past three decades. The recent introduction of immunotherapy as part of the initial chemotherapy regimens has contributed...
| Publicado en: | Cancers Vol. 18; no. 7; pp. 1129 - 1143 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
MDPI
Apr2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |